TRACON Pharmaceuticals, Inc. (TCON) Social Stream
Tracon Pharmaceuticals Inc (TCON) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TCON.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
TCON's average price target has moved up $8 over the prior 21 months.
TCON reports an average of 269.53% for its upside potential over the past 128 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
TCON Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
TCON's average broker recommendation rating improved by 0.67 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Tracon Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 279.06% of them.
- In the context of all US stocks, Tracon Pharmaceuticals Inc's average analyst price target is higher than 32.28% of them.
- TCON has a higher number of analysts covering the stock than 34.93% of all US stocks.
- In terms of how Tracon Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 16.51% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Tracon Pharmaceuticals Inc are TARA, RCOR, and PSTI.
Is TCON a Buy, Hold or Sell? See the POWR Ratings now!